Pages that link to "Q37989860"

The following pages link to Emerging roles of immunoproteasomes beyond MHC class I antigen processing (Q37989860):

Displaying 45 items.

• Immunoproteasome deficiency modifies the alternative pathway of NFκB signaling (Q21133685) (← links)
• Targeting the ubiquitin-proteasome system in heart disease: the basis for new therapeutic strategies (Q27026951) (← links)
• The immunoproteasome and viral infection: a complex regulator of inflammation (Q27694656) (← links)
• Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production (Q28114794) (← links)
• The ubiquitin proteasome system and myocardial ischemia (Q28280898) (← links)
• Mining kidney toxicogenomic data by using gene co-expression modules (Q28822270) (← links)
• Dysregulation of the (immuno)proteasome pathway in malformations of cortical development. (Q30804418) (← links)
• Functional module search in protein networks based on semantic similarity improves the analysis of proteomics data (Q30816361) (← links)
• The proteasome complex and the maintenance of pluripotency: sustain the fate by mopping up? (Q33673764) (← links)
• Identification of rheumatoid arthritis and osteoarthritis patients by transcriptome-based rule set generation (Q33766708) (← links)
• Immunoproteasome deficiency alters microglial cytokine response and improves cognitive deficits in Alzheimer's disease-like APPPS1 mice. (Q33831029) (← links)
• Modelling proteasome and proteasome regulator activities. (Q33912642) (← links)
• Regulating the 20S proteasome ubiquitin-independent degradation pathway (Q34318192) (← links)
• Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks (Q35132073) (← links)
• Regulation of immunoproteasome function in the lung (Q35623348) (← links)
• Histologic and Immunohistochemical Features of the Skin Lesions in CANDLE Syndrome (Q35764807) (← links)
• Proteasome β5i Subunit Deficiency Affects Opsonin Synthesis and Aggravates Pneumococcal Pneumonia (Q35995706) (← links)
• Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome. (Q36710603) (← links)
• Inhibitors of the immunoproteasome: current status and future directions (Q37292307) (← links)
• Current understanding on the role of standard and immunoproteasomes in inflammatory/immunological pathways of multiple sclerosis (Q37541906) (← links)
• IFN-γ directly controls IL-33 protein level through a STAT1- and LMP2-dependent mechanism (Q37727601) (← links)
• The 26S proteasome and initiation of gene transcription (Q38248373) (← links)
• Dysfunction in protein clearance by the proteasome: impact on autoinflammatory diseases (Q38473815) (← links)
• Interferon-γ-induced upregulation of immunoproteasome subunit assembly overcomes bortezomib resistance in human hematological cell lines (Q39034873) (← links)
• Identification of the immunoproteasome as a novel regulator of skeletal muscle differentiation. (Q39069554) (← links)
• Proteasome expression and activity in cancer and cancer stem cells (Q39201929) (← links)
• Interferon-dependent immunoproteasome activity during mouse adenovirus type 1 infection (Q39454584) (← links)
• Exposure to Melan-A/MART-126-35 tumor epitope specific CD8(+)T cells reveals immune escape by affecting the ubiquitin-proteasome system (UPS) (Q39796576) (← links)
• CANDLE Syndrome As a Paradigm of Proteasome-Related Autoinflammation (Q40067147) (← links)
• Impairment of Immunoproteasome Function by Cigarette Smoke and in Chronic Obstructive Pulmonary Disease (Q40836532) (← links)
• Immunoproteasome dysfunction augments alternative polarization of alveolar macrophages (Q41727507) (← links)
• Reduced Expression of the Antigen Processing Machinery Components TAP2, LMP2, and LMP7 in Tonsillar and Base of Tongue Cancer and Implications for Clinical Outcome (Q41815955) (← links)
• T lymphocytes export proteasomes by way of microparticles: a possible mechanism for generation of extracellular proteasomes (Q41923180) (← links)
• Low Neurotoxicity of ONX-0914 Supports the Idea of Specific Immunoproteasome Inhibition as a Side-Effect-Limiting, Therapeutic Strategy. (Q42372836) (← links)
• LPM7 Inhibitors May Potentially Treat Autoimmune Diseases (Q42732683) (← links)
• Impacts of Low Temperature on the Teleost Immune System (Q46256216) (← links)
• Proteasomes in Protein Homeostasis of Pluripotent Stem Cells (Q47098533) (← links)
• Pluripotent Stem Cell Model of Nakajo-Nishimura Syndrome Untangles Proinflammatory Pathways Mediated by Oxidative Stress. (Q54957638) (← links)
• Dopaminergic neurons show increased low-molecular-mass protein 7 activity induced by 6-hydroxydopamine in vitro and in vivo (Q58771881) (← links)
• Interplay between the Endogenous Opioid System and Proteasome Complex: Beyond Signaling (Q64065904) (← links)
• Aging attenuates redox adaptive homeostasis and proteostasis in female mice exposed to traffic-derived nanoparticles ('vehicular smog') (Q88515410) (← links)
• Gender-specific changes in energy metabolism and protein degradation as major pathways affected in livers of mice treated with ibuprofen (Q89882366) (← links)
• Proteasomal adaptations underlying carfilzomib-resistance in human bone marrow plasma cells (Q90602624) (← links)
• Contribution of the Unfolded Protein Response (UPR) to the Pathogenesis of Proteasome-Associated Autoinflammatory Syndromes (PRAAS) (Q91894003) (← links)
• Age-Dependent Effects of Immunoproteasome Deficiency on Mouse Adenovirus Type 1 Pathogenesis (Q92049885) (← links)